Dr. Greg Gerdeman is a neuroscientist and educator with expertise in the physiological actions of cannabis and the endocannabinoid system (ECS).

His Ph.D. dissertation was one of the first studies to discover endocannabinoids acting as “retrograde messengers” that regulate synaptic plasticity in the brain, findings that have become a foundation to modern understanding of the ECS and the neuroprotective actions of cannabis.

He is a member of international cannabinoid research and professional organisations, and has received funding from the National Institute on Drug Abuse (NIDA) and the National Science Foundation (NSF). He is extensively published and a vocal advocate to reclaim cannabis as a remarkably safe whole-plant medicine.